FOXP3 and breast cancer: implications for therapy and diagnosis

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.8, Iss.11, 2007-11, pp. : 1485-1487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Breast cancer staging: implications for therapy

Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Subtyping of triple-negative breast cancer: Implications for therapy

By Abramson Vandana G. Lehmann Brian D. Ballinger Tarah J. Pietenpol Jennifer A.

Cancer, Vol. 121, Iss. 1, 2015-01 ,pp. : 8-16

Blackwell Publishing

Access to resources Recommend Favorite

Targeting Brn-3b in breast cancer therapy

By Budhram-Mahadeo Vishwanie S Latchman David S

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. : 15-25

Informa Healthcare

Access to resources Recommend Favorite

Phytochemicals for Breast Cancer Therapy: Current Status and Future Implications

Current Cancer Drug Targets, Vol. 15, Iss. 2, 2015-02 ,pp. : 116-135

Bentham Science Publishers

Access to resources Recommend Favorite

Is There a Growing Role for Endocrine Therapy in the Treatment of Breast Cancer?

By Lønning P.E.

Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. : 11-21

Adis International

Access to resources Recommend Favorite